Photo from wikipedia
A phase 3 study of a levonorgestrel 52-mg intrauterine system in U.S. females shows high 5-year contraceptive efficacy and low hormonal adverse effect rates. Click to show full abstract
A phase 3 study of a levonorgestrel 52-mg intrauterine system in U.S. females shows high 5-year contraceptive efficacy and low hormonal adverse effect rates.
Keywords:
levonorgestrel intrauterine;
contraceptive efficacy;
intrauterine system;
year contraceptive
Journal Title: Obstetrics and Gynecology
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Obstetrics and Gynecology
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!